Met Life Investment Management, LLC Savara Inc Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Savara Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 59,049 shares of SVRA stock, worth $147,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,049

Previous 66,907 11.74%

Holding current value

$147,032

Previous $283,000 36.04%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$2.94 - $4.07 $23,102 - $31,982	-7,858 Reduced 11.74%	59,049 $181,000
Q3 2024 Nov 13, 2024	BUY	$3.96 - $5.07 $58,936 - $75,456	14,883 Added 28.61%	66,907 $283,000
Q2 2024 Aug 13, 2024	BUY	$3.66 - $5.34 $44,699 - $65,217	12,213 Added 30.68%	52,024 $209,000
Q1 2024 May 14, 2024	BUY	$4.19 - $5.59 $166,808 - $222,543	39,811 New	39,811 $198,000
Q4 2023 Feb 14, 2024	BUY	$3.18 - $4.9 $25,672 - $39,557	8,073 Added 19.91%	48,616 $228,000
Q3 2023 May 09, 2024	BUY	$2.97 - $3.88 $120,412 - $157,306	40,543 New	40,543 $153,000
Q2 2023 Apr 29, 2024	BUY	$1.69 - $3.24 $68,517 - $131,359	40,543 New	40,543 $129,000
Q2 2023 Aug 10, 2023	BUY	$1.69 - $3.24 $68,517 - $131,359	40,543 New	40,543 $129,000
Q2 2019 Jul 12, 2023	BUY	$2.37 - $11.7 $37,209 - $183,690	15,700 New	15,700 $37.2 Million
Q2 2019 Aug 14, 2019	SELL	$2.37 - $11.7 $37,209 - $183,690	-15,700 Closed	0 $0
Q1 2019 Jul 13, 2023	BUY	$6.71 - $8.6 $105,347 - $135,020	15,700 New	15,700 $115,000
Q1 2019 Mar 22, 2023	SELL	$6.71 - $8.6 $30,483 - $39,069	-4,543 Reduced 22.44%	15,700 $115,000
Q1 2019 May 15, 2019	BUY	$6.71 - $8.6 $105,347 - $135,020	15,700 New	15,700 $116,000
Q4 2018 Feb 14, 2019	SELL	$6.27 - $10.92 $126,923 - $221,053	-20,243 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$10.49 - $12.87 $136,863 - $167,914	13,047 New	13,047 $145,000
Q3 2018 Mar 22, 2023	BUY	$10.49 - $12.87 $212,349 - $260,527	20,243 New	20,243 $225,000
Q3 2018 Nov 14, 2018	BUY	$10.49 - $12.87 $75,486 - $92,612	7,196 Added 55.15%	20,243 $226,000
Q2 2018 Aug 15, 2018	BUY	$8.55 - $13.76 $111,551 - $179,526	13,047 New	13,047 $148,000

Others Institutions Holding SVRA

# of Institutions

141

Shares Held

158M

Call Options Held

55.6K

Put Options Held

600

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $284M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Savara Inc Transaction History